Portfolio · Therapeutic Category N

Nervous System

"Steadiness, dose after dose."

Neurology / mental health care setting, calm light

Neurological conditions now affect more than 1 in 3 people worldwide, every dose has to be exactly right.

Neurological conditions now affect more than 3 billion people worldwide, over one in three, making them the leading cause of illness and disability globally. Analgesics, anticonvulsants, and psychiatric medicines carry some of the narrowest tolerance for formulation drift in our entire portfolio, patients and caregivers notice small changes immediately.

Source: The Lancet Neurology / WHO, Global Burden of Disease Study, 2021.

Products in This Category

Filter by Product Type

Development Stage Sourcing Dossier Review Dossier Screening Product Submission Approval Launch

20 product(s) found

Product	Indication	Product Type	Dosage Form	Development Stage
Duloxetine30 mg	Major depressive disorder	Generic	Delayed-release capsule	Dossier Review
Duloxetine60 mg	Diabetic peripheral neuropathic pain	Generic	Delayed-release capsule	Dossier Review
Escitalopram10 mg	Major depressive disorder	Generic	Tablet	Product Submission
Escitalopram20 mg	Generalised anxiety disorder	Generic	Tablet	Product Submission
Pregabalin75 mg; 150 mg	Neuropathic pain	Generic	Capsule	Dossier Screening
Donepezil5 mg; 10 mg	Alzheimer's disease	Generic	Tablet	Dossier Screening
Memantine10 mg	Moderate to severe Alzheimer's disease	Generic	Tablet	Dossier Screening
Rasagiline1 mg	Parkinson's disease	Generic	Tablet	Sourcing
Valproic acid200 mg; 500 mg	Epilepsy, bipolar disorder	Generic	Tablet	Dossier Review
Lithium carbonate300 mg	Bipolar disorder	Generic	Tablet	Sourcing
Lorazepam1 mg; 2 mg	Anxiety, status epilepticus	Generic	Tablet	Sourcing
Zolpidem10 mg	Insomnia	Generic	Tablet	Dossier Screening
Eletriptan40 mg	Acute migraine	Generic	Tablet	Sourcing
Betahistine16 mg; 24 mg	Meniere's disease, vertigo	Generic	Tablet	Product Submission
Naltrexone50 mg	Opioid & alcohol dependence	Generic	Tablet	Sourcing
Buprenorphine2 mg; 8 mg	Opioid dependence	Generic	Sublingual tablet	Sourcing
Morphine10 mg; 30 mg / 10 mg/mL	Moderate to severe pain	Generic	Tablet / Injection	Dossier Screening
Propofol1% w/v, 20 mL	Induction of anaesthesia	Generic	Injectable emulsion	Dossier Review
Ropivacaine2 mg/mL; 7.5 mg/mL	Regional anaesthesia	Generic	Injection	Sourcing
Sevoflurane250 mL bottle	Inhalational anaesthesia	Generic	Inhalation liquid	Dossier Review